Alira Health

Alira Health

Management Consulting

Portfolio Management

Financial solutions tailored to your business goals

Benefit from customized solutions aimed at optimizing returns and managing risks through asset prioritization and diversification in adjacent markets with Alira Health Portfolio Management.

A proprietary methodology backed by experience

Many of our clients structure their company around a specific platform to develop many assets in very different markets. And while spreading risk over several assets is always positive, as companies face resource shortages, they need to focus on a limited number of opportunities with increased probabilities of success to convince investors.

To meet those needs, Alira Health has developed a proprietary methodology and associated tools to allow our clients to prioritize assets and define an investment strategy that ensures operational success and value creation.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • An integrated team with experience across the product lifecycle
  • Proprietary digital tools tailored to your business needs
  • Click here to see our approach in action for a leading pharmaceutical company

Connect with a Winning Team

See why Alira Health was named one of the world’s best management consulting firms by Forbes.

Related news

Events July 18, 2024
UXN Health 2024
Look for patient engagement expert Eduardo Perez onsite in Aarhus to connect on topics like integrating patient voices in solution design.
Co-Design MedTech Patient Engagement Pharma
Case Studies March 26, 2024
Pharma Company Overcomes Launch Challenges with Patient-Centric Strategy
Our patient engagement team helped this pharma client identify the drivers behind the challenges they faced with their product launch.
Patient Centricity Patient Engagement Pharma
Case Studies March 12, 2024
Pharma Company Adopts a Patient-Centric Value Proposition for Regulatory and Payer Dossier
A pharma company had a wealth of patient data on a product in development and they wanted to create a long-term strategy that would create a continuity of patient engagement across(...)
Patient Centricity Patient Engagement Pharma
News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
CDD CDMO Pharma
Events January 22, 2024
Pharmapack Europe
Connect with our Drug Delivery Systems and CDMO experts Aude Ouensanga, Giulia Valsecchi, and Michal Raciborski on site at Pharmapack Europe.
CDMO Drug Delivery Pharma
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.